Disorders of
gene expression are closely related to the
biological characteristics,
treatment response, and
prognosis of
hematological malignancies. The rapidly-developing
transcriptome sequencing and single-
cell transcriptome sequencing
technologies in recent years provide powerful tools for discovering marker
genes and studying
gene expression patterns related to
disease diagnosis and
treatment. This article reviews the related
research progress in conjunction with
reports at the 62nd American Society of
Hematology (
ASH) Annual Meeting.